C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/14 (2006.01) A61K 31/4439 (2006.01) A61K 31/4709 (2006.01) C07D 401/04 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2510298
Compounds are described which inhibit mitogen activated protein kinase- activated protein kinase-2 (MK-2). Methods of making such compounds are described, as well as a method of using them for the inhibition of MK-2, and for the prevention or treatment of a disease or disorder that is mediated by TNF.alpha., where the method involves administering to the subject an MK-2 inhibiting compound of the present invention. Pharmaceutical compositions and kits which contain the present MK-2 inhibiting compounds are also described.
L'invention concerne des composés qui inhibent une protéine kinase activée par un mitogène/une protéine kinase 2 activée (MK-2). Cette invention a également pour objet des méthodes d'élaboration de tels composés, ainsi qu'une méthode visant à les utiliser pour inhiber une protéine kinase 2 (MK-2) et pour prévenir ou traiter une maladie ou un trouble à médiation TNF.alpha.. Ladite méthode consiste à administrer au sujet un composé d'inhibition de MK-2 de la présente invention. Cette invention a aussi trait à des compositions pharmaceutiques et à des kits qui renferment lesdits composés d'inhibition de MK-2.
Buchler Ingrid P.
Graneto Matthew J.
Hanau Cathleen E.
Hegde Shridhar G.
Liu Shuang
Pharmacia Corporation
Smart & Biggar
LandOfFree
Acyclic pyrazole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyclic pyrazole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclic pyrazole compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2029442